Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
16 Mar, 2023, 11.42 AM IST
Midcap stocks with ‘strong buy’ & ‘buy’ reco which can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
09 Mar, 2023, 12.16 PM IST
Even as bears stay in control of Nifty, midcap stocks with ‘strong buy’ & ‘buy’ ratings can rally over 25%, say analystsNifty in a correction mode and how much time it will stay in that mode, it is anyone's guess. For all those who are busy guessing how thing...
02 Mar, 2023, 12.13 PM IST
Capping stent prices will halt new launches, says industryThe process may require the drug pricing watchdog to look at a set of separate parameters for these devices as compared to that for drugs.
21 Jul, 2016, 11.05 PM IST
- Big Pharma seeks biotech dose to spur growth
Vincent Aita of Kilkenny Capital Management says he picks biotechnology stocks on their potential as takeover targets.
13 Jan, 2007, 02.59 AM IST